A major locus on chromosome 3p22 conferring predisposition to human herpesvirus 8 infection

Eur J Hum Genet. 2012 Jun;20(6):690-5. doi: 10.1038/ejhg.2011.260. Epub 2012 Jan 18.

Abstract

Infection with human herpesvirus 8 (HHV-8), the etiological agent of Kaposi's sarcoma, has been shown to display strong familial aggregation, in countries in which HHV-8 infection is endemic. We investigated 40 large families (608 subjects aged one to 88 years) living in an isolated area of Cameroon in which HHV-8 is highly endemic. We performed a two-step genetic analysis for HHV-8 infection status (HHV-8+/HHV-8- determined by immunofluorescence) consisting of an initial segregation analysis followed by a model-based genome-wide linkage analysis. Overall HHV-8 seroprevalence was 60%, increasing with age. Segregation analysis provided strong evidence for a recessive major gene conferring predisposition to HHV-8 infection. This gene is predicted to have a major effect during childhood, with almost all homozygous predisposed subjects (∼7% of the population) becoming infected by the age of 10. Linkage analysis was carried out on the 15 most informative families, corresponding to 205 genotyped subjects. A single region on chromosome 3p22 was significantly linked to HHV-8 infection (LOD score=3.83, P=2.0 × 10(-5)). This study provides the first evidence that HHV-8 infection in children in endemic areas has a strong genetic basis involving at least one recessive major locus on chromosome 3p22.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Viral / immunology
  • Cameroon
  • Child
  • Child, Preschool
  • Chromosomes, Human, Pair 3 / genetics*
  • Family
  • Female
  • Genes, Recessive
  • Genetic Predisposition to Disease*
  • Herpesviridae Infections / genetics*
  • Herpesviridae Infections / transmission
  • Herpesviridae Infections / virology*
  • Herpesvirus 8, Human / immunology
  • Herpesvirus 8, Human / pathogenicity*
  • Humans
  • Infant
  • Male
  • Middle Aged
  • Seroepidemiologic Studies

Substances

  • Antibodies, Viral